Impact of pharmacist intervention on the utilization of sitagliptin use in the ckd
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-HPS-077
- By: LEE, Chi-Hui (China Taiwan)
- Co-author(s): Chi-Hui Lee
BackgroundSitagliptin is the first DPP-IV inhibitor and studies have demonstrated that appropriate reductions dose in chronic kidney disease (CKD) patients.
PurposeThis study was to evaluate the impacts of pharmacist intervention on sitagliptin utilization in chronic kidney disease .
MethodsThis study was divided into three periods of repetitive.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019